Experts say the apparent effects of a weekly dose of tirzepatide are potentially game changing
A weekly dose of a diabetes drug appears to lead to significant weight loss in people with obesity, in a development experts have hailed as game-changing.
Obesity causes 1.2 million deaths in Europe each year, according to the World Health Organisation, and the UK has one of the worst obesity rates.
